Skip to content
Health Policy Watch
  • Home
  • About Us
  • Antimicrobial Resistance
  • Infectious Diseases
  • Pandemics & Emergencies
  • Non-Communicable Diseases
  • Health, Climate & SDGs
More Than Half Of People With HIV Now Have Access To Treatment, UNAIDS Says
20/07/2017 William New
For the first time, more than half of people in the world living with HIV have access to treatment, UNAIDS said in a report released today in Geneva. In addition, AIDS-related deaths have been nearly cut in half since 2005, it said. As of 2016, nearly 20 million people were living with HIV. Continue reading ->
Medicines Patent Pool Nets WHO’s Kieny As New Chair
03/07/2017 Catherine Saez
Marie-Paule Kieny, fresh out of the World Health Organization, where she held the position of assistant director general for Health Systems and Innovation, will be the new chair of the Medicines Patent Pool, as of 1 September. Continue reading ->
Major Research Funders, Institutions Pledge Transparency In Clinical Trials
18/05/2017 William New
More transparency on clinical trials is expected after major research funders, research institutions, and international health groups agreed that the research they fund or support will publicly release results of clinical trials. Continue reading ->
New Industry Alliance Aimed At Antimicrobial Resistance
18/05/2017 Catherine Saez
Pharmaceutical industry representatives today announced a new alliance to fight antimicrobial resistance. The announcement came during a meeting of the private sector of the most advanced countries. Continue reading ->
WHO Touts Its Past Work On Improving Access To Medicines
11/05/2017 Elise De Geyter
The World Health Organization today published an item entitled, Access to medicines: making market forces serve the poor, a chapter from its report ‘Ten years in public health 2007-2017’ of outgoing WHO Director General Margaret Chan. Continue reading ->
WHO Project To Prequalify Biosimilar Cancer Medicines Aims At Increased Affordability
04/05/2017 Catherine Saez
The World Health Organization announced today that it will launch a pilot project in 2017 for prequalifying cancer biosimilar medicines, with the intent of lowering prices on some of the most expensive cancer treatments. Continue reading ->

Posts navigation

Newer posts
This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Sign up for free news alerts
Signup Link
Contact Us
info@healthpolicy-watch.org
1-5 Route des Morillions CP 2100
Geneva 1211, Switzerland
+41 22 791 67 28
About
Privacy Policy
Archives
Staff Access
Log in
Entries RSS
Comments RSS
Wordpress.org
Supported by
Sponsors
Wellcome
HeDPAC
Geneva
Loro
Copyright c 2020 Global Policy Reporting